Official UK procurement notice
The Supply, Delivery and Maintenance of a Live Cell Imaging Instrument
Authority: MEDICINES DISCOVERY CATAPULT LIMITED (Public body)
What is being bought
Published requirement descriptionThe supply, delivery and maintenance of a Live Cell Imager.
CPV: Laboratory, optical and precision equipments (excl. glasses)
The lotProcurement structure
single lot · no lot value publishedLot #1The supply, delivery and maintenance of a Live Cell Imager for the TRFID facility (cat…
The supply, delivery and maintenance of a Live Cell Imager for the TRFID facility (cat 3 laboratories) for Medicines Discovery Catapult located in Alderley Park.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
Procedure terms & legal framework
From the official record- Procedure method
- Negotiated without publication of a contract notice
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 1 Dec 2021, 12:22 GMT
- Last source update
- 1 Dec 2021, 12:22 GMT
- Authority reference
DN584991- FTS notice number
2021/S 000-029793- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02fbd7Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Live cell imaging (and analysis) capability with the following specifications is required for the CAT 3 lab facility for the Medicines Discovery Catapult:
- Both phase and fluorescence image capture in both 2D (Eg. proliferation, cell viability assays) and 3D (Eg. organoid) cell models enables the wide range of assays required to be run.
- Capacity to image multiple plates (using different protocols) at the same time, this is due to the flexibility required as the MDC works on various / multiple projects and needs this level of flexibility to efficiently perform the required experiments. The ability to simultaneously run different assays measuring unrelated endpoints is required to increase lab capacity, reducing time by running concurrent experiments.
- Automation of imaging and remote access to live experiments is required to reduce scientist time in the CAT 3 laboratory which is required from a Health and Safety perspective and also a resource perceptive from the vetting of staff required to access the CAT 3 facilities. This is a safety aspect required for a containment level 3 laboratory and makes continuous 24 hour timepoints more manageable.
- In addition to microtiter plates the instrument must be compatible with a selection of tissue culture plastics and microscope slides.
- Space is limited in the TRFID /CAT 3 facility and means that the instrument must have a compact footprint, either a benchtop instrument or the size of a standard cell culture incubator.
The Incucyte SX5 live- cell analysis system is the only system on the market that fulfils all of these requirements thus competition is absent for technical reasons and this purchase is being processed under sole source.
MDC will undertake a 10 day standstill period. If no challenges are received during the standstill period the MDC will continue to award the contract to Sartorius. The standstill period will end at midnight on Monday 13th December 2021.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Sartorius UK Limited | £150,000 † | — | Awarded |
Contracts
Contract 029793-2021-1 · Sartorius UK Limited
- Signed
- 30 Nov 2021
- Value
- £150,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Medicines Discovery Catapult LtdReview body
Bidders & participating suppliers
1 commercial party on the notice- Sartorius UK LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.